Loading…
Reported covered position: worked for Rep. Brewster '92-'96
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Enhanced Health Care Value for All Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Enhanced Health Care Value for All Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MCBRIDE CLINIC via CAPITOL HILL CONSULTING GROUP
2008 · third_quarter · 3T
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Drug and Medical Device Company Gift Disclosure Act
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Drug and Medical Device Company Gift Disclosure Act
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Medicare Improvements for Patients and Providers Act of 2008
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Medicare Improvements for Patients and Providers Act of 2008
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
Medicare Improvements for Patients and Providers Act of 2008
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
Medicare Improvements for Patients and Providers Act of 2008
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Comparative Effectiveness Research Act of 2008
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Comparative Effectiveness Research Act of 2008
Client: PHRMA · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
Terminally Ill Disability Beneficiary Act of 2003
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
Terminally Ill Disability Beneficiary Act of 2003
Client: MCBRIDE CLINIC · Firm: CAPITOL HILL CONSULTING GROUP
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
PHRMA via CAPITOL HILL CONSULTING GROUP
2008 · fourth_quarter · Q4
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2008 · fourth_quarter · Q4
general education issues, no specific bills
General appropriations issues for the University; FY09 Appropriations for agriculture, commerce, justice, science, defense, energy and water; Financial Services; Homeland Security; Interior and Environment; Labor; HHS and Education
2008 Defense Authorization Bill
general Homeland Security issues
2009 Farm Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via CAPITOL HILL CONSULTING GROUP
2008 · third_quarter · Q3
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts: Physician Payments Sunshine Act (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041); Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173); Medicare Prescription Price Negotiation Act (HR 4/S. 3). Medicare Improvements for Patients and Providers Act (HR 6331)
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2008 · third_quarter · Q3
2008 Defense Authorization Bill
2009 Farm Bill
general education issues, no specific bills
general homeland security issues
General Appropriations issues for the University; FY09 Appropriations for agriculture; commerce, justice, science; defense; energy and water; financial services; homeland security; interior and environment; Labor, HHS and Educations
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
MCBRIDE CLINIC via CAPITOL HILL CONSULTING GROUP
2008 · third_quarter · 3T
General healthcare issues related to physician-owned specialty hospitals. Restrictions on physician-owned specialty hospitals included in the following bills: Mental Health Parity Act (S.558); Children's Health Insurance Program Reauthorization Act (HR 976); Medicare Improvements for Patients and Providers Act (HR 6331); Supplemental Appropriations Act (HR 2642).
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREGNANCY CARE CENTER via CAPITOL HILL CONSULTING GROUP
2008 · third_quarter · 3T
Assisting with applications for federal grants and project funds to assist with program expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE CLINIC via CAPITOL HILL CONSULTING GROUP
2008 · second_quarter · 2A
General healthcare issues
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREGNANCY CARE CENTER via CAPITOL HILL CONSULTING GROUP
2008 · second_quarter · Q2
Assisting with applications for federal grants and project funds to assist with program expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via CAPITOL HILL CONSULTING GROUP
2008 · second_quarter · Q2
General Healthcare Issues
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
General Tax Issues
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2008 · second_quarter · Q2
general defense issues
general agricultural issues
general homeland security issues
general appropriations issues for the University
MCBRIDE CLINIC via CAPITOL HILL CONSULTING GROUP
2008 · second_quarter · Q2
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
General healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHRMA via CAPITOL HILL CONSULTING GROUP
2008 · first_quarter · 1A
General Healthcare Issues
General Tax issues
General Medicare and Medicare issues, including but not limited to, coverage and reimbursement
PHRMA via CAPITOL HILL CONSULTING GROUP
2008 · first_quarter · Q1
General Medicare and Medicare issues, including but not limited to, coverage and reimbursement
General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act: the Hatch-Waxman Act: patent reform; drug importation; and drug safety
General Healthcare Issues
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2008 · first_quarter · Q1
General appropriations issues for the University
General agricultural issues
general homeland security issues
MCBRIDE CLINIC via CAPITOL HILL CONSULTING GROUP
2008 · first_quarter · Q1
General healthcare issues
General Medicare and Medicaid issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHRMA via CAPITOL HILL CONSULTING GROUP
2007 · year_end · YA
General healthcare issues.
General medicare issues
General tax issues
General pharmaceutical issues
PHRMA via CAPITOL HILL CONSULTING GROUP
2007 · year_end · YY
General pharmaceutical issues
General healthcare issues.
General medicare issues
General tax issues
General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act; the Hatch-Waxman Act; patent reform; drug importation; and drug safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
general education issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act: the Hatch-Waxman Act: patent reform; drug importation; and drug safety
General Tax issues
general defense issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE